Unknown

Dataset Information

0

Longitudinal neutralization activities on authentic Omicron variant provided by three doses of BBIBP-CorV vaccination during one year.


ABSTRACT: The majority of people in China have been immunized with the inactivated viral vaccine BBIBP-CorV. The emergence of the Omicron variant raised the concerns about protection efficacy of the inactivated viral vaccine in China. However, longitudinal neutralization data describing protection efficacy against Omicron variant is still lacking. Here we present one-year longitudinal neutralization data of BBIBP-CorV on authentic Omicron, Delta, and wild-type strains using 224 sera collected from 14 volunteers who have finished three doses BBIBP-CorV. The sera were also subjected for monitoring the SARS-CoV-2 specific IgG, IgA, and IgM responses on protein and peptide microarrays. The neutralization titers showed different protection efficacies against the three strains. By incorporating IgG and IgA signals of proteins and Spike protein derived peptide on microarray, panels as potential surrogate biomarkers for rapid estimation of neutralization titers were established. These data support the necessity of the 3rd dose of BBIBP-CorV vaccination. After further validation and assay development, the panels could be used for reliable, convenient and fast evaluation of the efficacy of vaccination.

SUBMITTER: Lai DY 

PROVIDER: S-EPMC9874883 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Longitudinal neutralization activities on authentic Omicron variant provided by three doses of BBIBP-CorV vaccination during one year.

Lai Dan-Yun DY   Xue Jun-Biao JB   He Ping P   Jiang He-Wei HW   Li Yang Y   Ma Ming-Liang ML   Hong Wei W   Yu Jun-Ping JP   Wei Hong-Ping HP   Tao Sheng-Ce SC  

Proteomics 20221017 2


The majority of people in China have been immunized with the inactivated viral vaccine BBIBP-CorV. The emergence of the Omicron variant raised the concerns about protection efficacy of the inactivated viral vaccine in China. However, longitudinal neutralization data describing protection efficacy against Omicron variant is still lacking. Here we present one-year longitudinal neutralization data of BBIBP-CorV on authentic Omicron, Delta, and wild-type strains using 224 sera collected from 14 volu  ...[more]

Similar Datasets

| S-EPMC9762096 | biostudies-literature
| S-EPMC9317843 | biostudies-literature
| S-EPMC10116389 | biostudies-literature
| S-EPMC8785690 | biostudies-literature
| S-EPMC9239573 | biostudies-literature
| S-EPMC8809504 | biostudies-literature
| S-EPMC10223200 | biostudies-literature
| S-EPMC9420027 | biostudies-literature